| Psychopharmacological treatment of schizophrenia over time in 30 908 inpatients: data from the AMSP study S Toto, R Grohmann, S Bleich, H Frieling, HB Maier, W Greil, J Cordes, ... International Journal of Neuropsychopharmacology 22 (9), 560-573, 2019 | 42 | 2019 |
| Therapeutic drug monitoring of second-and third-generation antipsychotic drugs—influence of smoking behavior and inflammation on pharmacokinetics N Moschny, G Hefner, R Grohmann, G Eckermann, HB Maier, J Seifert, ... Pharmaceuticals 14 (6), 514, 2021 | 27 | 2021 |
| Alcohol consumption alters Gdnf promoter methylation and expression in rats HB Maier, M Neyazi, A Neyazi, T Hillemacher, H Pathak, M Rhein, ... Journal of psychiatric research 121, 1-9, 2020 | 25 | 2020 |
| Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy N Moschny, T Zindler, K Jahn, M Dorda, CF Davenport, L Wiehlmann, ... Clinical epigenetics 12, 1-16, 2020 | 18 | 2020 |
| S100B, homocysteine, vitamin B12, folic acid, and procalcitonin serum levels in remitters to electroconvulsive therapy: a pilot study H Maier, S Helm, S Toto, N Moschny, W Sperling, T Hillemacher, KG Kahl, ... Disease Markers 2018 (1), 2358451, 2018 | 13 | 2018 |
| Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study K Druschky, S Toto, S Bleich, J Baumgärtner, RR Engel, R Grohmann, ... The World Journal of Biological Psychiatry 22 (5), 373-386, 2021 | 11 | 2021 |
| Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patients N Moschny, K Jahn, HB Maier, AQ Khan, M Ballmaier, K Liepach, M Sack, ... European Neuropsychopharmacology 36, 18-28, 2020 | 11 | 2020 |
| DNA methylation of the t-PA gene differs between various immune cell subtypes isolated from depressed patients receiving electroconvulsive therapy N Moschny, K Jahn, M Bajbouj, HB Maier, M Ballmaier, AQ Khan, ... Frontiers in psychiatry 11, 571, 2020 | 7 | 2020 |
| Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001–2017 J Seifert, HB Maier, F Führmann, S Bleich, S Stübner, M Sieberer, ... Journal of Neural Transmission 129 (7), 925-944, 2022 | 6 | 2022 |
| Distinct promoter regions of the oxytocin receptor gene are hypomethylated in Prader-Willi syndrome and in Prader-Willi syndrome associated psychosis HM Heseding, K Jahn, CK Eberlein, J Wieting, HB Maier, ... Translational Psychiatry 12 (1), 246, 2022 | 5 | 2022 |
| Psychiatrische Autoimmunenzephalitis–Diagnose und therapeutische Ansätze N Hansen, D Lüdecke, HB Maier, J Steiner, AN Neyazi PSYCH up2date 17 (01), 13-28, 2023 | 3 | 2023 |
| Epinephrine levels decrease in responders after electroconvulsive therapy C Pollak, HB Maier, N Moschny, K Jahn, S Bleich, H Frieling, A Neyazi Journal of Neural Transmission 128, 1917-1921, 2021 | 3 | 2021 |
| Clinical and sociodemographic predictors of inpatient admission after presentation in a psychiatric emergency room: an observational study GL Gisy, S Toto, S Bleich, HB Maier, J Seifert International journal of mental health systems 17 (1), 44, 2023 | 1 | 2023 |
| Psychopharmaka in der Praxis: Ein Blick auf Antipsychotika J Seifert, HB Maier, S Toto, D Dabbert DMW-Deutsche Medizinische Wochenschrift 148 (09), 563-575, 2023 | 1 | 2023 |
| DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy HB Maier, N Moschny, F Eberle, K Jahn, T Folsche, R Schülke, S Bleich, ... Pharmacopsychiatry 56 (02), 64-72, 2023 | 1 | 2023 |
| Predictors of response to electroconvulsive therapy: A new role for tissue-type plasminogen activator and plasminogen activator inhibitor 1 N Moschny, A Neyazi, H Maier, K Jahn, A Khan, M Bajouj, S Bleich, ... European Neuropsychopharmacology 29, S388-S388, 2019 | 1 | 2019 |
| Epigenetic alterations in patients with anorexia nervosa—a systematic review L Käver, A Hinney, LS Rajcsanyi, HB Maier, H Frieling, H Steiger, C Voelz, ... Molecular Psychiatry, 1-15, 2024 | | 2024 |
| Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedicated Control Group HB Maier, A Borchert, A Neyazi, N Moschny, R Schülke, GL Bundies, ... Pharmacopsychiatry, 2024 | | 2024 |
| Psychopharmaka in der Praxis: Ein Blick auf Antipsychotika J Seifert, HB Maier, S Toto, D Dabbert PSYCH up2date 18 (03), 253-267, 2024 | | 2024 |
| Validation of the predictive value of BDNF-87 methylation for antidepressant treatment success in severely depressed patients—a randomized rater-blinded trial HB Maier, A Neyazi, GL Bundies, F Meyer-Bockenkamp, S Bleich, ... Trials 25 (1), 247, 2024 | | 2024 |
